Laboratory Corp Of America Holdings (LH): Lisa J Uthgenannt , Chief Human Resources Officer of Laboratory Corp Of America Holdings sold 3,740 shares on Apr 29, 2016. The Insider selling transaction was reported by the company on May 13, 2016 to the Securities and Exchange Commission. The shares were sold at $125.17 per share for a total value of $468,135.81 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 29, 2016, Edward T Dodson (Principal Accounting Officer) sold 9,392 shares at $126.42 per share price.On Mar 15, 2016, James T. Jr. Boyle (EVP,CEO of LabCorp Diagnostics) sold 1,543 shares at $115.32 per share price.Also, On Mar 15, 2016, F Samuel Iii Eberts (Chief Legal Officer, Secretary) sold 309 shares at $115.32 per share price.On Feb 29, 2016, Jean-luc Belingard (director) sold 1,296 shares at $109.72 per share price.
Laboratory Corp. of America Holdings: On Tuesday, May 10, 2016 heightened volatility was witnessed in Laboratory Corp. of America Holdings which led to swings in the share price. The shares opened for trading at $125.45 and hit $126.76 on the upside , eventually ending the session at $126.7, with a gain of 1.41% or 1.76 points. The heightened volatility saw the trading volume jump to 7,93,991 shares. The 52-week high of the share price is $128.84 and the company has a market cap of $12,974 M . The 52-week low of the share price is at $97.79.
Company has been under the radar of several Street Analysts.Laboratory Corp. of America Holdings is Reiterated by Mizuho to Neutral and the brokerage firm has raised the Price Target to $ 132 from a previous price target of $119 .The Rating was issued on Apr 26, 2016.Laboratory Corp. of America Holdings is Reiterated by Canaccord Genuity to Buy and the brokerage firm has raised the Price Target to $ 140 from a previous price target of $135 .The Rating was issued on Apr 26, 2016.Laboratory Corp. of America Holdings is Reiterated by Barclays to Overweight and the brokerage firm has raised the Price Target to $ 155 from a previous price target of $152 .The Rating was issued on Apr 26, 2016.Laboratory Corp. of America Holdings is Initiated by Credit Suisse to Outperform. The Rating was issued on Mar 16, 2016.Laboratory Corp. of America Holdings is Reiterated by RBC Capital Mkts to Sector Perform while Lowering the Price Target of the company shares to $ 130 from a previous price target of $135 . The Rating was issued on Feb 19, 2016.
Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing patient diagnosis and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment which includes core testing as well as genomic and esoteric testing; and the Other segment which consists of the Company’s non-United States clinical diagnostic laboratory operations in Ontario Canada. It also provides specialty testing services in the areas of allergy clinical trials diagnostic genetics women’s health cardiovascular disease identity forensics infectious disease endocrinology oncology coagulation occupational testing and pain management.